SCHEMBL24944367

SCHEMBL24944367

CNc1nc(Nc2ccc(N3CCOCC3)cc2F)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK9 P45984 5/20 0.48
▸ MAPK10 P53779 5/20 0.48
▸ ZAP70 P43403 1/20 0.40
▸ MAPK8 P45983 2/20 0.40
▸ LRRK2 Q5S007 3/20 0.39
▸ ALK Q9UM73 6/20 0.39
▸ EML4 Q9HC35 3/20 0.38
▸ JAK3 P52333 2/20 0.38
▸ JAK2 O60674 2/20 0.38
▸ IGF1R P08069 2/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ STAT6 P42226 1/20 0.38
▸ CAMKK2 Q96RR4 2/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ MAPK15 Q8TD08 1/20 0.37
▸ PTK2 Q05397 3/20 0.36
▸ INSR P06213 2/20 0.36
▸ RET P07949 2/20 0.36
▸ ROS1 P08922 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205517 1.00 MAPK9 (0.48) MAPK9MAPK10ZAP70MAPK8LRRK2
SCHEMBL29173445 0.92 ZAP70 (0.43) MAPK9MAPK10ZAP70MAPK8LRRK2
SCHEMBL24944156 0.92 MAPK9 (0.40) MAPK9MAPK10ZAP70MAPK8LRRK2
SCHEMBL24943795 0.91 MAPK9 (0.44) MAPK9MAPK10ZAP70MAPK8LRRK2
SCHEMBL24944969 0.91 LRRK2 (0.51) MAPK9MAPK10ZAP70MAPK8LRRK2
SCHEMBL24944442 0.89 RET (0.37) MAPK9MAPK10ZAP70MAPK8LRRK2
SCHEMBL24943791 0.89 EML4 (0.48) ALKEML4JAK3RETROS1
SCHEMBL24944783 0.88 LRRK2 (0.41) MAPK9MAPK10LRRK2ALKEML4
SCHEMBL24943794 0.88 RET (0.38) MAPK9MAPK10MAPK8LRRK2ALK
SCHEMBL24944164 0.88 RET (0.36) MAPK9MAPK10MAPK8LRRK2ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback